Home › Stocks › NBY

NovaBay Pharmaceuticals, Inc. (NBY): insider buying, hedge funds & Congress trades

NovaBay Pharmaceuticals, Inc. (NBY): 7 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Apr 15, 2025Poplar Point Capital Management Llc
TenPercentOwner
102,388$0.66$67.8Kno history
Apr 15, 2025Fakhry Jad
TenPercentOwner
84,487$0.66$55.6Kno history
Apr 15, 2025Fakhry Jad
TenPercentOwner
48,930$0.61$29.8Kno history
Apr 15, 2025Poplar Point Capital Gp Llc
TenPercentOwner
64,175$0.62$39.5Kno history
Apr 15, 2025Fakhry Jad
TenPercentOwner
49,927$0.62$30.7Kno history
Apr 15, 2025Poplar Point Capital Partners Lp
TenPercentOwner
123,365$0.60$74.6Kno history
Apr 15, 2025Fakhry Jad
TenPercentOwner
28,731$0.55$15.9Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for NBY

Free account. Know when insiders, famous funds or Congress trade it.

Start free